INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to anti-cancer treatment evaluations and early toxicity studies. Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage. This breaking-thought technology, based on chick embryo, provides early analysis of your treatments before the classical preclinical stages. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity and reduces its costs. It’s rapid Go/No Go decision with multi-cancer screening capacities. This next generation of in vivo efficacy and toxicity tests covers fours main aspects: - EFFICACY assays for your anti-cancer treatments - EARLY TOXICITY assays for your drug candidates - TARGET VALIDATION in oncology - MULTI-CANCER SCREENING to (re)positioning your treatment We help chemists and biologists from companies and universities to validate a target and develop treatments by getting them through in vivo evaluation, while staying within their budget. These accessible efficacy and toxicity assays open really new perspectives of screening for wide variety of project researches with a rapid Go/No Go decisions. You want focus your R&D on your high-value molecules, contact us!" title="" class="btn" data-container="body" data-html="true" data-id="85525" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="INOVOTION"> 3,132
Activities
Technologies
Entity types
Location
5 Av. du Grand Sablon, 38700 La Tronche, France
La Tronche
France
Employees
Scale: 11-50
Estimated: 19
SIREN
811310127Engaged catalyst
20Added in Motherbase
5 years, 1 month agoWhich molecule will stand out
INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to anti-cancer treatment evaluations and early toxicity studies.
Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage.
This breaking-thought technology, based on chick embryo, provides early analysis of your treatments before the classical preclinical stages. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity and reduces its costs. It’s rapid Go/No Go decision with multi-cancer screening capacities.
This next generation of in vivo efficacy and toxicity tests covers fours main aspects:
- EFFICACY assays for your anti-cancer treatments
- EARLY TOXICITY assays for your drug candidates
- TARGET VALIDATION in oncology
- MULTI-CANCER SCREENING to (re)positioning your treatment
We help chemists and biologists from companies and universities to validate a target and develop treatments by getting them through in vivo evaluation, while staying within their budget.
These accessible efficacy and toxicity assays open really new perspectives of screening for wide variety of project researches with a rapid Go/No Go decisions.
You want focus your R&D on your high-value molecules, contact us!
In Vivo Anti-Cancer Drug Evaluations, Target Validation, In Vivo Toxicology, Which Molecule Will Stand Out, and Multi-Cancer Screenning
Which molecule will stand out
INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to anti-cancer treatment evaluations and early toxicity studies.
Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage.
This breaking-thought technology, based on chick embryo, provides early analysis of your treatments before the classical preclinical stages. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity and reduces its costs. It’s rapid Go/No Go decision with multi-cancer screening capacities.
This next generation of in vivo efficacy and toxicity tests covers fours main aspects:
- EFFICACY assays for your anti-cancer treatments
- EARLY TOXICITY assays for your drug candidates
- TARGET VALIDATION in oncology
- MULTI-CANCER SCREENING to (re)positioning your treatment
We help chemists and biologists from companies and universities to validate a target and develop treatments by getting them through in vivo evaluation, while staying within their budget.
These accessible efficacy and toxicity assays open really new perspectives of screening for wide variety of project researches with a rapid Go/No Go decisions.
You want focus your R&D on your high-value molecules, contact us!
Which molecule will stand out
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | Le Réseau des Carnot | Other 28 Feb 2025 | | |
![]() BASF Chemistry, Chemical Manufacturing | BASF Chemistry, Chemical Manufacturing | Other 25 Feb 2025 | | |
![]() Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 18 Nov 2024 | | |
![]() Institut Curie Health, Hospitals and Health Care | Institut Curie Health, Hospitals and Health Care | Other 22 Oct 2024 | | |
![]() Eurostat European Union, Environmental Services | Eurostat European Union, Environmental Services | Other 4 Nov 2024 | | |
![]() | Invest In Grenoble Alpes | Other 2 May 2024 | | |
![]() AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 30 Jun 2024 | | |
![]() CNRS Research, Research Services | CNRS Research, Research Services | Other 14 Feb 2025 | | |
![]() Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Other 30 May 2024 | | |
![]() CEA Research | CEA Research | Other 30 May 2024 | |